Skip to main content
. 2021 Apr 22;74(2):259–268. doi: 10.5173/ceju.2021.0374

Table 6.

Geographical, clinical and surgical details of patients experiencing postoperative death

Age Risk region COVID-19-free facility Nasopharyngeal swab before admission Surgical procedure Surgical approach Cause of death Postoperative nasopharyngeal swab
70 High Yes No URS Endoscopic AMI Positive
69 Medium Yes Yes Cytoreductive nephrectomy Open Pneumonia Not performed
89 Medium No No TURBT Endoscopic Unknown Not performed
70 Medium Yes No Radical cystectomy Open Sepsis Negative
75 High No No Radical nephrectomy Laparoscopic Sarcoma end stage Not performed
43 High No No Percutaneous nephrostomy Percutaneous Malignant mammary tumor Not performed
81 High No No TURBT Endoscopic Pneumonia Positive
82 High No No Double J ureteral stenting Endoscopic Pneumonia Positive
82 High No No TURBT Endoscopic Pneumonia Not performed
79 High No No Radical nephrectomy Open Peritonitis and MOF secondary to duodenal lesion Not performed
85 High Yes No Double J ureteral stenting Endoscopic Unknown Not performed
79 High Yes No Radical nephrectomy Laparoscopic Gastrointestinal bleeding Positive
73 High Yes No Radical cystectomy Robotic Pneumonia Positive

AMI – acute myocardial infarction; MOF: – multiorgan failure, TURBT – transurethral resection of bladder tumor; URS – ureterorenoscopy